Diseases, Conditions, Syndromes

Experimental drug may work against hepatitis C

(HealthDay)—An experimental therapy for hepatitis C—a "silent killer" linked to liver cancer and cirrhosis—has shown promise in tamping down virus levels in early trials.

Diseases, Conditions, Syndromes

Better long-term outcomes with low hep C viral load

(HealthDay)—In patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), low HCV viral load predicts better long-term surgical outcomes, regardless of the serologic eradication of HCV, according to research ...

Diseases, Conditions, Syndromes

UN warns risk of hepatitis E in S. Sudan grows

(AP)—The United Nations says an outbreak of hepatitis E has killed 111 refugees in camps in South Sudan since July, and has become endemic in the region.

HIV & AIDS

Predicting survival among those aging with HIV infection

(Medical Xpress)—A new collaborative study led by Yale, the VA Healthcare System, and the North American Cohort Collaboration supports the accuracy of an index used for predicting mortality as patients with HIV age. The ...

Diseases, Conditions, Syndromes

Targeting hepatitis C treatment: The importance of interleukin (IL)-28

A metanalysis published in BioMed Central's open access journal BMC Medicine has confirmed that polymorphisms (SNP) in the gene coding for interleukin-28 (IL28B) influence natural hepatitis C viral (HCV) clearance and response ...

page 18 from 24